Search filters

List of works by Emmanuel S. Antonarakis

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016

A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts

scientific article published on 02 July 2020

A New Molecular Taxonomy to Predict Immune Checkpoint Inhibitor Sensitivity in Prostate Cancer

scientific article published on 09 January 2019

A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells

scientific article published on 5 June 2015

A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer

scientific article published on 14 July 2017

A cut above.

scientific article published in December 2007

A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer.

scientific article

A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer ⬇️

scientific article published on January 13, 2013

A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination

scientific article

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer

scientific article published on 06 February 2019

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

scientific article published on 13 June 2019

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

scientific article

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

scientific article published on 01 June 2020

A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study.

scientific article

A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA

A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer

scientific article published on 30 July 2019

A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer

scientific article published on 14 October 2019

AR Signaling in Human Malignancies: Prostate Cancer and Beyond

scientific article published on 18 January 2018

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

scientific article

AR-V7 and treatment selection in advanced prostate cancer: are we there yet?

scholarly article published September 2018

Abiraterone acetate for prostate cancer: a new era of hormonal therapies.

scientific article published on 11 July 2011

Abiraterone acetate: a hat trick of clinical benefits ⬇️

scientific article published on November 9, 2012

Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born.

scientific article

Abiraterone for the Treatment of Advanced Prostate Cancer ⬇️

scientific article published on September 1, 2012

Abiraterone plus olaparib in prostate cancer: a new form of synthetic lethality?

scientific article published on 04 June 2018

Abstract 646: Liquid biopsy transcriptomics identify pathways associated with poor outcomes and immune phenotypes in men with mCRPC

scientific article published in 2022

Acute psychological stress-induced water intoxication.

scientific article published in January 2005

Altering the Natural History of Oligometastatic Prostate Cancer With Local Therapies: Reality Versus Illusion

scientific article published on 3 January 2017

An atypical complication of atypical pneumonia

scientific article published on 01 October 2006

An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy ⬇️

scientific article published on June 6, 2012

Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer

scientific article published on 10 May 2016

Analytical Validation of Androgen Receptor Splice Variant 7 Detection in a Clinical Laboratory Improvement Amendments (CLIA) Laboratory Setting

scientific article published on December 2016

Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate Cancer

scientific article published on 18 September 2019

Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

scientific article

Androgen pathway resistance in prostate cancer and therapeutic implications

scientific article

Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations.

scientific article published on 3 June 2016

Androgen receptor splice variants in the era of enzalutamide and abiraterone

scientific article

Androgen receptor variant-driven prostate cancer II: advances in clinical investigation

scientific article published on 24 February 2020

Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations

scientific article published on 05 March 2020

Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination

scientific article

Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall Survival

scientific article published on 01 June 2018

Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer

scientific article published on 02 July 2020

Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel

scientific article published on 14 February 2014

BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations

scientific article published on 16 October 2017

BRCA1 Versus BRCA2 and PARP Inhibitor Sensitivity in Prostate Cancer: More Different Than Alike?

scientific article published on 01 September 2020

Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study

scientific article

Bipolar Androgen Therapy: A Paradoxical Approach for the Treatment of Castration-resistant Prostate Cancer.

scientific article

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study

scientific article published on 13 December 2017

Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy

scientific article published on 28 December 2020

Blocking the PD-1/PD-L1 axis in advanced prostate cancer: are we moving in the right direction?

Blood Based Detection of Androgen Receptor Splice Variants in Patients with Advanced Prostate Cancer.

scientific article

Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases ⬇️

scientific article published on April 17, 2012

CDK12 Deficiency and the Immune Microenvironment in Prostate Cancer

scientific article published on 16 November 2020

CDK12 inactivation across solid tumors: an actionable genetic subtype

scientific article published on 10 May 2019

CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors

scientific article published on 21 April 2020

CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer

scientific article published on 10 January 2018

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer ⬇️

scientific article published on March 10, 2011

Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint

scientific article published on 04 December 2018

Castration-resistant prostate cancer: latest evidence and therapeutic implications

scientific article

Changes in PSA kinetics predict metastasis- free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents: combined analysis of 4 phase II trials

scientific article published on March 2012

Circulating Tumor Cell Eradication as an Intermediate Efficacy End Point for Metastatic Castration-Resistant Prostate Cancer: Is There Enough Evidence?

scientific article published on 22 December 2017

Circulating Tumor Cells in Advanced Prostate Cancer: Time to Move from Prognostic to Predictive Ability

scientific article published on 31 August 2016

Circulating tumor cell-based or tissue biopsy-based AR-V7 detection: which provides the greatest clinical utility?

scientific article published on 01 December 2019

Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer

scientific article published on July 2013

Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations

article

Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer

scientific article

Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer

scientific article published on December 2015

Clinical Significance of AR-V567es in Prostate Cancer-Response

scientific article published on 01 October 2019

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide

scientific article published on 6 April 2017

Clinical Utility of CLIA-Grade AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer

scientific article published on 30 October 2017

Clinical activity of enzalutamide in Docetaxel-naïve and Docetaxel-pretreated patients with metastatic castration-resistant prostate cancer

scientific article

Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone

scientific article published on 22 July 2014

Clinical implications of mismatch repair deficiency in prostate cancer

scientific article published on 25 June 2019

Clinical outcomes associated with pathogenic genomic instability mutations in prostate cancer: a retrospective analysis of US pharmacy and medical claims data

scientific article published on 28 August 2019

Clinical problem-solving. Beware of first impressions

scientific article

Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine

scientific article published on 02 July 2021

Combining active immunotherapy with immune checkpoint blockade for the treatment of advanced prostate cancer.

scientific article published on 14 May 2012

Combining active immunotherapy with immune checkpoint blockade for the treatment of advanced prostate cancer.

scientific article published on 2 July 2012

Combining immunological and androgen-directed approaches: an emerging concept in prostate cancer immunotherapy

scientific article

Combining low-dose cyclophosphamide with GM-CSF-secreting prostate cancer immunotherapy enhances antitumor immune effects

scientific article

Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study

scientific article

Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer

scientific article published on 22 October 2015

Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies

article

Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer

scientific article published on 22 March 2018

Cost-Savings Analysis of AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer Eligible for Treatment With Abiraterone or Enzalutamide

scientific article published on 12 July 2016

Current status of immunological approaches for the treatment of prostate cancer ⬇️

scientific article published on May 1, 2012

Current status of immunological therapies for prostate cancer.

scientific article published on May 2010

Current understanding of resistance to abiraterone  and enzalutamide in advanced prostate cancer

scientific article published in May 2016

Cyclin-Dependent Kinase 12, Immunity, and Prostate Cancer

scientific article published on 01 September 2018

Cytokine profile of sipuleucel-T (sip-T) in differentiating reactivation of latent immunity from de novo immune responses. ⬇️

scholarly article

Darolutamide For Castration-Resistant Prostate Cancer

scientific article published on 23 October 2019

Detection fidelity of AR mutations in plasma derived cell-free DNA

scientific article published on 31 January 2017

Detection of AR-V7 transcript with RNA in situ hybridization in human salivary duct cancer

scientific article published on 28 June 2018

Detection of circulating tumor DNA in early- and late-stage human malignancies

scientific article (publication date: 19 February 2014)

Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation.

scientific article

Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations

scientific article published on 21 February 2019

Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer

scientific article published on 28 November 2019

Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13

scientific article published on 29 May 2018

Do Patients With AR-V7-Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions

scientific article published on 31 August 2016

Does degree of androgen suppression matter in hormone-sensitive prostate cancer?

scientific article published on 2 March 2015

Does sequencing order of antiandrogens in prostate cancer matter?

scientific article published on 01 April 2020

Does short-term ADT before and during radiation therapy improve outcomes in locally advanced prostate cancer?

scientific article

Editorial Comment

Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study

scientific article

Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis.

scientific article

Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects

article

Emerging Molecular Biomarkers in Advanced Prostate Cancer: Translation to the Clinic

scientific article

Emerging treatments for metastatic castration-resistant prostate cancer: Immunotherapy, PARP inhibitors, and PSMA-targeted approaches

scientific article published on 07 January 2020

Enzalutamide in chemo-naïve castration-resistant prostate cancer: effective for most but not for all.

scientific article published on November 2014

Enzalutamide: The emperor of all anti-androgens

scientific article

Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer ⬇️

scientific article published on April 4, 2013

Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium

scientific article published on 16 August 2018

Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer ⬇️

scientific article published on May 17, 2011

Expanding treatment options for metastatic prostate cancer

scientific article published on May 2011

Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration

scientific article published on 28 April 2017

Expression of AR-V7 and ARv567es in circulating tumor cells correlates with outcomes to taxane therapy in men with metastatic prostate cancer treated in TAXYNERGY

scientific article published on 09 October 2018

Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer

scientific article published on 23 January 2020

Favorable Response to Pembrolizumab in a Patient With Metastatic Castration-Resistant Prostate Cancer Progressing While Receiving Enzalutamide

scientific article published on 06 December 2018

Flagellate erythema secondary to bleomycin ⬇️

scientific article published on August 24, 2011

Future Directions in Castrate-Resistant Prostate Cancer Therapy ⬇️

scientific article published on December 1, 2010

Galeterone for the treatment of advanced prostate cancer: the evidence to date

scientific article

Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate Cancer

scientific article published on 03 April 2019

Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene Mutations

scientific article published on 18 April 2019

Genomic and Clinical-Pathologic Characterization of ATM-deficient Prostate Cancer

scientific article published on 21 July 2020

Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype

scientific article published on 07 August 2019

Germline BLM mutations and metastatic prostate cancer

scientific article published on 05 November 2019

Germline DNA Repair Mutations and Response to Hormonal Therapy in Advanced Prostate Cancer

scientific article published on 15 March 2017

Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide

scientific article published on 10 February 2018

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium

scientific article published on 18 April 2019

Germline genetic testing in prostate cancer - further enrichment in variant histologies?

scientific article published in March 2018

Growth factor and signaling pathways and their relevance to prostate cancer therapeutics

scientific article

High-dose itraconazole as a noncastrating therapy for a patient with biochemically recurrent prostate cancer

scientific article

Hormonal Therapy or Chemotherapy for Metastatic Prostate Cancer - Playing the Right CARD

scientific article published on 01 December 2019

Images in clinical medicine. Acquired leukonychia totalis.

scientific article published in July 2006

Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC).

scientific article published on 4 November 2015

Immunotherapy for prostate cancer enters its golden age ⬇️

scientific article published on July 10, 2012

Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer

scientific article published on 04 July 2020

In hormone-naive metastatic prostate cancer, should all patients now receive docetaxel? Yes; we must beware of drawing conclusions from a subset analysis.

scientific article published in October 2014

Inherited HSD3B1 polymorphisms and hormonal therapy resistance

scientific article

Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

scientific article

Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer

scientific article

Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer.

scientific article published on 19 June 2018

Is abiraterone acetate well tolerated and effective in the treatment of castration-resistant prostate cancer?

scientific article

Lenalidomide in Nonmetastatic Biochemically Relapsed Prostate Cancer: Results of a Phase I/II Double-Blinded, Randomized Study ⬇️

scientific article published on October 26, 2010

Lenalidomide modulates IL‐8 and anti‐prostate antibody levels in men with biochemically recurrent prostate cancer ⬇️

scientific article published on July 11, 2011

Liquid biopsy: Clues on prostate cancer drug resistance

scientific article published in November 2015

Long‐term overall survival and metastasis‐free survival for men with prostate‐specific antigen‐recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database ⬇️

scientific article published on November 23, 2010

Lumbosacral Plexus Involvement as the First Site of Metastatic Recurrence in a Patient With CTNNB1-Mutant Prostate Cancer.

scientific article published on 23 February 2016

MSH2 Loss in Primary Prostate Cancer

scientific article published on 8 August 2017

Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions ⬇️

scientific article published on January 1, 2013

Management of metastatic castration-resistant prostate cancer

scientific article published on January 2011

Management of patients with biochemical recurrence after local therapy for prostate cancer

scientific article

Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy

scientific article published on 26 November 2019

Medical hospitalizations in prostate cancer survivors

scientific article published on 20 June 2016

Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer

scientific article published on 11 June 2020

Metastatic Hormone-Sensitive Prostate Cancer: Clinical Decision Making in a Rapidly Evolving Landscape of Life-Prolonging Therapy

scientific article published on 10 September 2019

Microsatellite instability in prostate cancer by PCR or next-generation sequencing.

scientific article published on 17 April 2018

Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical Prostatectomy

scientific article published on 26 July 2019

Molecular heterogeneity of localized prostate cancer: more different than alike

scientific article published on February 2017

Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.

scientific article published on 16 July 2013

Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors

Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial

scientific article

NCCN Guidelines Updates: Management of Prostate Cancer

scientific article published on 01 May 2019

Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice

scientific article published on September 2004

Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance

scientific article published on 10 July 2020

Not what it seems

scientific article published in May 2007

Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer

scientific article

Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer

scientific article published on 30 August 2017

Novel mechanism-based therapeutics for androgen axis blockade in castration-resistant prostate cancer

scientific article published on 14 March 2016

Novel targeted therapeutics for metastatic castration-resistant prostate cancer.

scientific article

Olaparib for DNA repair-deficient prostate cancer - one for all, or all for one?

scientific article published on 23 May 2020

Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer

scientific article published on 26 August 2015

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines

scientific article published on 04 March 2020

Orientation of the stethoscope around the neck: a random phenomenon or an indicator of cerebral lateralisation? Cross-sectional survey

scientific article

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

scientific article published on 26 March 2020

Overall survival (OS) and biomarker results from combat: A phase 2 study of bipolar androgen therapy (BAT) plus nivolumab for patients with metastatic castrate-resistant prostate cancer (mCRPC).

scientific article published in 2022

PARP Inhibitors in Metastatic Prostate Cancer: Evidence to Date

scientific article published on 07 September 2020

PARP inhibition - not all gene mutations are created equal

scientific article published on 01 January 2019

PARP inhibitors for homologous recombination-deficient prostate cancer

scientific article published on 29 March 2018

PARP inhibitors in prostate cancer: time to narrow patient selection?

scientific article published on 10 June 2020

PD-1/PD-L1 pathway inhibitors in advanced prostate cancer

scientific article published on 24 April 2018

PD09-05 DIFFERENCES IN GENOMIC, TRANSCRIPTOMIC AND IMMUNE LANDSCAPE OF PROSTATE CANCER (PCA) BASED ON SITE OF METASTASIS (METS) ⬇️

scholarly article

PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

scientific article published on 21 August 2019

PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer

scientific article published on 14 April 2016

Pan-Cancer Analysis of CDK12 Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype

scientific article published on 10 July 2019

Paraneoplastic Palmar Fasciitis and Polyarthritis Syndrome in a Patient With Advanced Prostate Cancer ⬇️

scientific article published on June 29, 2013

Patterns of Recurrence and Modes of Progression Following Metastasis Directed Therapy in Oligometastatic Castration Sensitive Prostate Cancer

scientific article published on 13 August 2020

Pemberton sign

scientific article published on 01 July 2007

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study

scientific article published on 27 November 2019

Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy

scientific article published on 26 October 2017

Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer

scientific article published on 8 November 2016

Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort

scientific article published on 05 May 2016

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial

scientific article published on 22 October 2011

Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer

scientific article published on 23 October 2019

Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers

scientific article

Phase III Trials With Docetaxel-Based Combinations for Metastatic Castration-Resistant Prostate Cancer: Time to Learn From Past Experiences ⬇️

scientific article published on April 8, 2013

Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC

scientific article published on 28 September 2020

Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9(®) to Suppress Enzalutamide-resistant Prostate Cancer Progression

scientific article published on 18 May 2017

Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-naïve prostate cancer cells

scientific article published on 10 September 2020

Predicting treatment response in castration-resistant prostate cancer: could androgen receptor variant-7 hold the key?

scientific article published on 30 December 2014

Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage

scientific article published on 31 August 2018

Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications

scientific article

Prognostic and therapeutic implications of DNA repair gene mutations in advanced prostate cancer

scientific article

Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor-directed therapies

scientific article

Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence?

scientific article

Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors

scientific article published on 10 May 2019

Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer

scientific article published on 28 October 2020

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study

scientific article published on 13 March 2019

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 May 2019

Prostate angiosarcoma: a case report and literature review ⬇️

scientific article published on February 17, 2012

Prostate angiosarcoma: is there any association with previous radiation therapy? ⬇️

scientific article published on May 15, 2012

Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide

scientific article

Prostate cancer: AR splice variant dimerization-clinical implications

scientific article published on 01 August 2015

Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience

scientific article published on 13 August 2019

Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial

scientific article published on 11 May 2019

Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale

scientific article published on 01 July 2019

Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer

scientific article

Recovery From Bicalutamide-Associated Pneumonitis in a Patient With ATM-Deficient Prostate Cancer

scientific article published on 27 July 2020

Reimagining vaccines for prostate cancer: Back to the future

scientific article published on 31 July 2020

Reply to C. Ren et al

scientific article published on 12 June 2018

Reply to Julie Steinestel, Christof Bernemann, Andres J. Schrader, and Jochen K. Lennerz's Letter to the Editor re: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, et al. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detectio

scientific article

Reply to L. Dirix, B. De Laere et al, and A. Sharp et al

scientific article published on 02 July 2019

Reply to Salma Kaochar, Nicholas Mitsiades' Letter to the Editor re: Umang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al. Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. Eur

scientific article published on 05 January 2021

Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer.

scientific article

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

scientific article

Rheumatoid arthritis masked by docetaxel chemotherapy in a patient with ovarian carcinoma

scientific article

Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302

scientific article published on 01 June 2019

Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors

scientific article published on 28 September 2020

Ruthenium-based chemotherapeutics: are they ready for prime time?

scientific article

Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone

scientific article published on 17 February 2017

Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer

Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis

scientific article published on 26 October 2020

Sequencing Treatment for Castration-Resistant Prostate Cancer

scientific article published on December 2016

Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial

scientific article published on 10 November 2016

Sipuleucel-T (sip-T) induced lytic CD8+ T cell responses to target antigens in men with hormone-sensitive and castration-resistant prostate cancer (CRPC). ⬇️

scholarly article

Sipuleucel-T for the treatment of metastatic prostate cancer: promise and challenges.

scientific article published on April 2012

Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions

scientific article

Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment

scientific article published on 06 September 2018

Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage

scientific article published on 16 July 2019

Surgical Resection of Malignant Melanoma Metastatic to the Pancreas: Case Series and Review of Literature ⬇️

scientific article published on September 1, 2012

Surrogate end points in early prostate cancer clinical states: ready for implementation?

scientific article published in December 2017

Survival in men with nonmetastatic prostate cancer treated with hormone therapy: a quantitative systematic review.

scientific article

T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer

scientific article published on 15 March 2020

TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?

scientific article published on 10 April 2020

Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.

scientific article published on 20 December 2017

Targeting ELK1: a wELKome addition to the prostate cancer armamentarium

scientific article published on 31 October 2018

Targeting angiogenesis for the treatment of prostate cancer ⬇️

scientific article published on March 13, 2012

Targeting lineage plasticity in prostate cancer

scientific article published on 09 September 2019

Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer.

scientific article published on 14 September 2016

Temperature modulation of DHPLC analysis for detection of coexisting constitutional and mosaic sequence variants in TSC2.

scientific article published in April 2002

The Experience with Cytotoxic Chemotherapy in Metastatic Castration-Resistant Prostate Cancer ⬇️

scientific article published on November 1, 2012

The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer

scientific article published on 01 June 2020

The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited

scientific article published on 05 January 2021

The STAMPEDE trial: paradigm-changing data through innovative trial design

scientific article

The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen Deprivation ⬇️

scientific article published on March 22, 2011

The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer.

scientific article published on 15 June 2012

The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer

scientific article published on 08 October 2013

The effect of therapeutic anticoagulation on overall survival in men receiving first-line docetaxel chemotherapy for metastatic castration-resistant prostate cancer

scientific article

The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation

scientific article published on 20 December 2017

The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer

scientific article published on August 2017

The influence of prior abiraterone treatment on the clinical activity of docetaxel in men with metastatic castration-resistant prostate cancer

scientific article

The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up

scientific article published on 20 July 2011

The unfolding treatment landscape for men with castration-resistant prostate cancer ⬇️

scientific article published on November 1, 2011

Therapeutic targeting of the DNA damage response in prostate cancer

scientific article published on 01 May 2020

Treatment strategies for DNA repair-deficient prostate cancer

scientific article published on 2 June 2017

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

scientific article

Tumor frameshift mutation proportion predicts response to immunotherapy in mismatch repair-deficient prostate cancer

scientific article published on 20 November 2020

Tumorigenic potential of circulating prostate tumor cells.

scientific article published on March 2013

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

scientific article published on 16 April 2018

Update: immunological strategies for prostate cancer.

scientific article published on May 2010

Use of androgen deprivation therapy in prostate cancer: indications and prevalence ⬇️

scientific article published on 09 January 2012

Very-high-risk localized prostate cancer: definition and outcomes

scientific article published on 5 November 2013

Visual vignette. Necrobiosis lipoidica

scientific article published on 01 May 2007

When and How to Use PARP Inhibitors in Prostate Cancer: A Systematic Review of the Literature with an Update on On-Going Trials

scientific article published on 17 August 2020

Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer

scientific article published on 05 June 2019

p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer

scientific article published on 4 January 2018

α-Particle-Emitter Radiopharmaceutical Therapy: Resistance Is Futile

scientific article published on 01 November 2019

Paulina is supported by:

About Paulina

Help